Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma

doi:10.3748/wjg.15.4962

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 39

This Article

(0)

(5188)

(62)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Brief Article

World J Gastroenterol. Oct 21, 2009; 15(39): 4962-4968
Published online Oct 21, 2009. doi: 10.3748/wjg.15.4962

Full Size Figure Download Figure

Figure 1 Three-year survival (OR: 1. 76, 95% CI: 1.42-2.19, P = 0.11). OR: Odds ratio; CI: Confidence interval; CRTS: Neoadjuvant chemoradiotherapy; S: Surgery alone.

Citation: Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15(39): 4962-4968
URL: https://www.wjgnet.com/1007-9327/full/v15/i39/4962.htm
DOI: https://dx.doi.org/10.3748/wjg.15.4962

Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15(39): 4962-4968 [PMID: 19842230 DOI: 10.3748/wjg.15.4962]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.